FOXP3 and cervical cancer: In post-NACT patients, the peritumoral Foxp3+ T cell to intratumoral CD8+ T cells ratio serves as a critical predictor of survival, with lower ratios being positively correlated with improved PFS and overall survival in locally advanced cervical cancer (41).